A selective A2A adenosine receptor agonist in myocardial imaging.
相关文献及参考
[2]. Golzar Y, et al. Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge. Int J Chron Obstruct Pulmon Dis. 2014;9:129-137. Published 2014 Jan 22.
[3]. Jackson S, et al. The effect of regadenoson on the integrity of the human blood-brain barrier, a pilot study. J Neurooncol. 2017;132(3):513-519.
Gordi, T., et al.: J. Clin. Pharmacol., 47, 825 (2007),
Palle, V.P., et al.: J. A. Drug Dev. Res., 50, 64 (2000),
[1]. Palle VP, et al. Structure-affinity relationships of the affinity of 2-pyrazolyl adenosine analogues for the adenosine A2A receptor. Bioorg Med Chem Lett. 2002;12(20):2935-2939.
[1]. Palle VP, et al. Structure-affinity relationships of the affinity of 2-pyrazolyl adenosine analogues for the adenosine A2A receptor. Bioorg Med Chem Lett. 2002;12(20):2935-2939.
[2]. Golzar Y, et al. Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current